IVE vs XBI

iShares S&P 500 Value ETF vs SPDR S&P Biotech ETF

Quick take
  • IVE has the lower expense ratio at 0.18% vs 0.35% for XBI.
  • IVE pays a higher dividend yield (1.56%).

Side-by-side metrics

MetricIVEXBI
Expense ratio
Annual fee. Lower is better.
0.18%0.35%
Dividend yield
Trailing 12-month yield.
1.56%0.36%
AUM
Assets under management — bigger funds are typically more liquid.
$47.74B$10.73B
YTD return
8.76%33.79%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.791.10
P/E ratio
23.75
Last price
$230.04$164.01
Inception
Issuer
iSharesState Street

IVE top holdings

Top holdings · IVE
AAPLApple Inc7.32%
AMZNAmazon.com Inc3.78%
INTCIntel Corp2.27%
XOMExxon Mobil Corp1.95%
WMTWalmart Inc1.71%
TSLATesla Inc1.55%
COSTCostco Wholesale Corp1.43%
UNHUnitedHealth Group Inc1.30%
BACBank of America Corp1.28%
HDThe Home Depot Inc1.21%
Sector breakdown · IVE
Real Estate3.3%
Consumer Cyclical10.6%
Basic Materials3.3%
Consumer Defensive8.8%
Technology21.7%
Communication Services2.9%
Financial Services15.0%
Utilities4.4%
Industrials10.9%
Energy6.6%
Healthcare12.2%

XBI top holdings

Top holdings · XBI
APGEApogee Therapeutics Inc1.49%
MRNAModerna Inc1.41%
TWSTTwist Bioscience Corp1.41%
ORKAOruka Therapeutics Inc1.38%
KYMRKymera Therapeutics Inc Ordinary Shares1.36%
VKTXViking Therapeutics Inc1.30%
PRAXPraxis Precision Medicines Inc Ordinary Shares1.29%
ERASErasca Inc1.27%
RVMDRevolution Medicines Inc Ordinary Shares1.20%
RYTMRhythm Pharmaceuticals Inc1.20%
Sector breakdown · XBI
Financial Services0.5%
Healthcare99.5%

About IVE

IVE (iShares S&P 500 Value ETF) is S&P 500 value subset. Managed by iShares, the fund carries $47.7B in assets under management, an expense ratio of 0.18%, a dividend yield of 1.56%. Its largest holding is Apple Inc (AAPL), which represents 7.3% of the portfolio. Real Estate is the fund's largest sector exposure at 3.3%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.